1-4 of 4
Carrie L. Cummings
Close
Sort by
Journal Articles

Myeloid/Lymphoid Neoplasm with Eosinophilia and a Novel RUFY1-Pdgfrb Rearrangement

Karly Williams Silva, Carrie L. Cummings, Nahid Rashid, Olga Sala-Torra, Xueyan Chen, Yajuan J. Liu, Vivian G. Oehler
Journal: Blood
Blood (2021) 138 (Supplement 1): 4639.
https://doi.org/10.1182/blood-2021-151703
Published: 2021
Journal Articles

Custom High Throughput Drug Sensitivity Assay Reveals Therapeutic Options for Chronic Myeloid Leukemia Patients Resistant to or Intolerant of Tyrosine Kinase Inhibitors

Vivian G. Oehler, Sylvia Chien, Jin Dai, Carrie L. Cummings, James Annis, Timothy J Martins, Pamela S. Becker
Journal: Blood
Blood (2021) 138 (Supplement 1): 268.
https://doi.org/10.1182/blood-2021-151933
Published: 2021
Journal Articles

The preferentially expressed antigen in melanoma (PRAME) inhibits myeloid differentiation in normal hematopoietic and leukemic progenitor cells

Vivian G. Oehler, Katherine A. Guthrie, Carrie L. Cummings, Kathleen Sabo, Brent L. Wood, Ted Gooley, Taimei Yang, Mirjam T. Epping, Yaping Shou, Era Pogosova-Agadjanyan, Paula Ladne, Derek L. Stirewalt, Janis L. Abkowitz, Jerald P. Radich
Journal: Blood
Blood (2009) 114 (15): 3299–3308.
https://doi.org/10.1182/blood-2008-07-170282
Published: 2009
Includes: Supplemental data
Journal Articles

Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation

Paula G. Heller, Ana C. Glembotsky, Manish J. Gandhi, Carrie L. Cummings, Carlos J. Pirola, Rosana F. Marta, Laura I. Kornblihtt, Jonathan G. Drachman, Felisa C. Molinas
Journal: Blood
Blood (2005) 105 (12): 4664–4670.
https://doi.org/10.1182/blood-2005-01-0050
Published: 2005